OTC Markets Group Welcomes Vapotherm, Inc. to OTCQX
15 Dezembro 2023 - 9:00AM
OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets
for 12,000 U.S. and international securities, today announced
Vapotherm, Inc. (OTCQX: VAPO), a global medical technology company
specializing in the development and commercialization of its
proprietary Vapotherm high-velocity therapy® products for patients
of all ages experiencing respiratory distress, has qualified to
trade on the OTCQX® Best Market. Vapotherm, Inc. voluntarily
transferred to OTCQX from the New York Stock Exchange.
Vapotherm, Inc. begins trading today on OTCQX under the symbol
“VAPO.” U.S. investors can find current financial disclosure and
Real-Time Level 2 quotes for the company on www.otcmarkets.com.
Trading on the OTCQX Market offers companies efficient,
cost-effective access to the U.S. capital markets. Streamlined
market requirements for OTCQX are designed to help companies lower
the cost and complexity of being publicly traded, while providing
transparent trading for their investors. To qualify for OTCQX,
companies must meet high financial standards, follow best practice
corporate governance, and demonstrate compliance with applicable
securities laws.
Commenting on the move to OTCQX, Joseph Army, Vapotherm’s CEO,
stated, “We have been evaluating our options for some time and have
concluded that, for Vapotherm, the cost of an NYSE listing, and the
management attention required to maintain compliance with NYSE
listing standards, outweighs the benefits of trading on that
exchange. Eliminating the effort required to maintain compliance
with NYSE size and price standards will better enable us to focus
on our customers, our business, and the patients whose lives are
enhanced as a result of our work.
About Vapotherm, Inc.Vapotherm, Inc. (NYSE:
VAPO) is a publicly traded developer and manufacturer of advanced
respiratory technology based in Exeter, New Hampshire, USA. The
Company develops innovative, comfortable, non-invasive technologies
for respiratory support of patients with chronic or acute breathing
disorders. Over 4.1 million patients have been treated with the use
of Vapotherm high velocity therapy® systems. For more information,
visit www.vapotherm.com.
Vapotherm high velocity therapy is mask-free non-invasive
respiratory support and is a front-line tool for relieving
respiratory distress—including hypercapnia, hypoxemia, and dyspnea.
It allows for the fast, safe treatment of undifferentiated
respiratory distress with one tool. The HVT 2.0 and Precision Flow
systems’ mask-free interface delivers optimally conditioned
breathing gases, making it comfortable for patients and reducing
the risks and care complexities associated with mask therapies.
While being treated, patients can talk, eat, drink and take oral
medication.
About OTC Markets Group Inc.OTC Markets Group
Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000
U.S. and international securities. Our data-driven disclosure
standards form the foundation of our three public markets: OTCQX®
Best Market, OTCQB® Venture Market and Pink® Open Market.
Our OTC Link® Alternative Trading Systems (ATSs) provide
critical market infrastructure that broker-dealers rely on to
facilitate trading. Our innovative model offers companies more
efficient access to the U.S. financial markets.
OTC Link ATS, OTC Link ECN and OTC Link NQB are each an SEC
regulated ATS, operated by OTC Link LLC, a FINRA and SEC registered
broker-dealer, member SIPC.
To learn more about how we create better informed and more
efficient markets, visit www.otcmarkets.com.
Subscribe to the OTC Markets RSS Feed
Media Contact:OTC Markets Group Inc., +1 (212)
896-4428, media@otcmarkets.com
Vapotherm (NYSE:VAPO)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Vapotherm (NYSE:VAPO)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024